APA (7th ed.) Citation

MA, F., C, H., KR, H., YJ, M., C, C., T, K., . . . C, B. (2018). Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(18), 4416. https://doi.org/10.1158/1078-0432.CCR-17-3649

Chicago Style (17th ed.) Citation

MA, Forget, et al. "Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 24, no. 18 (2018): 4416. https://doi.org/10.1158/1078-0432.CCR-17-3649.

MLA (9th ed.) Citation

MA, Forget, et al. "Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 24, no. 18, 2018, p. 4416, https://doi.org/10.1158/1078-0432.CCR-17-3649.